Filing Details

Accession Number:
0001179110-10-008943
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-19 13:00:00
Reporting Period:
2010-05-17
Filing Date:
2010-05-19
Accepted Time:
2010-05-19 16:59:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158223 Affymax Inc AFFY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362520 Arlene Morris C/O Affymax, Inc.
4001 Miranda Ave.
Palo Alto CA 94304
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-17 1,066 $4.36 1,066 No 4 M Direct
Common Stock Disposition 2010-05-17 966 $25.00 100 No 4 S Direct
Common Stock Disposition 2010-05-17 100 $25.01 0 No 4 S Direct
Common Stock Acquisiton 2010-05-18 2,229 $4.36 2,229 No 4 M Direct
Common Stock Acquisiton 2010-05-18 26,666 $10.99 28,895 No 4 M Direct
Common Stock Acquisiton 2010-05-18 22,935 $4.36 51,830 No 4 M Direct
Common Stock Disposition 2010-05-18 51,830 $25.06 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-05-17 1,066 $0.00 1,066 $4.36
Common Stock Stock Option (Right to Buy) Disposition 2010-05-18 2,229 $0.00 2,229 $4.36
Common Stock Stock Option (Right to Buy) Disposition 2010-05-18 26,666 $0.00 26,666 $10.99
Common Stock Stock Option (Right to Buy) Disposition 2010-05-18 22,935 $0.00 22,935 $4.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,229 2016-02-09 No 4 M Direct
0 2016-02-09 No 4 M Direct
53,334 2019-01-14 No 4 M Direct
0 2016-02-09 No 4 M Direct
Footnotes
  1. This transaction was pursuant to a 10b5-1 Plan.
  2. The shares subject to the option are exercisable upon grant. The shares vest monthly over 4 years.
  3. The shares were sold at prices between $25.00 and $25.22. The reporting person will provide upon request to the SEC, teh issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from January 1, 2009.